Skip to main content
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ETON ISIN · US29772L1089 US Manufacturing
Open in API
Filings indexed 358 across all filing types
Latest filing 2020-03-05 Annual Report
Country US United States of America
Listing US ETON

About Eton Pharmaceuticals, Inc.

https://etonpharma.com/

Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company's strategy involves sourcing, acquiring, and developing therapies to serve small, underserved patient populations. Eton manages the complete drug development lifecycle, from navigating clinical trials and the regulatory approval process to bringing the final products to market. It actively seeks meaningful therapies from a global network of partners to build a diversified portfolio of treatments.

Recent filings

Filing Released Lang Actions
Annual Report 2019
Annual Report FY 2019
2020-03-05 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text indicates it is an 8-K filing dated February 19, 2020, for Eton Pharmaceuticals, Inc. It includes an Item 8.01 Other Events section describing a press release update on a product candidate under FDA review, and an Item 9.01 Financial Statements and Exhibits section referencing the press release as Exhibit 99.1. The document is relatively short (3339 characters) and primarily serves as an announcement of an event and attached press release rather than a detailed financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like 8-Ks that do not fit other specific categories.
2020-02-19 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-14 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-04 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text specifically mentions an "Other Events" section describing a co-promotion agreement and includes a press release as an exhibit. There are no financial statements or detailed financial data presented, and the document is relatively short (3573 characters). It is not an annual or quarterly report, nor an earnings release. The content is an announcement of a corporate event rather than a detailed report. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-01-21 English
Regulatory Filings 2019
Regulatory Filings
2019-12-17 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.